Pacira BioSciences (PCRX) Convertible Debt (2013 - 2025)
Pacira BioSciences' Convertible Debt came in at $280.27 million for Q2 2025, down 41.6% from $479.55 million a year earlier but up 0.2% from the prior quarter.
Powered by 
Analysis
Pacira BioSciences (PCRX) Convertible Debt (2013 - 2025) Analysis & Trends
At the end of FY2024, Pacira BioSciences' Convertible Debt was $279.33 million, down 29.9% from FY2023.
- Convertible Debt carries a five-year compound annual growth rate of -1.8% (FY2019 to FY2024).
- Going back by year, Convertible Debt was $398.59 million in FY2023 (-1.5%), $404.77 million in FY2022 (+19.3%), $339.27 million in FY2021 (+8.4%) and $313.03 million in FY2020 (+2.3%).
- The five-year range for quarterly Convertible Debt is $278.87 million (Q3 2024) to $479.55 million (Q2 2024).
- Year-over-year, Convertible Debt has declined for four consecutive quarters, with an average decline of 14.4% over the last eight quarters.
- The fastest year-over-year change in Convertible Debt over five years came in Q3 2020 (growth of 51.1%), and the weakest in Q2 2025 (a decline of 41.6%).
- Business Quant data shows PCRX's Convertible Debt at $279.8 million (Q1 2025), $279.33 million (Q4 2024) and $278.87 million (Q3 2024) in the three quarters before Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Pacira BioSciences | 1.43 Bn | 495.69 Mn | 148.24 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | 280.27 Mn |
| Mar 31, 2025 | 279.80 Mn |
| Dec 31, 2024 | 279.33 Mn |
| Sep 30, 2024 | 278.87 Mn |
| Jun 30, 2024 | 479.55 Mn |
| Mar 31, 2024 | 399.21 Mn |
| Dec 31, 2023 | 398.59 Mn |
| Sep 30, 2023 | 397.98 Mn |
| Jun 30, 2023 | 397.36 Mn |
| Mar 31, 2023 | 405.38 Mn |
| Dec 31, 2022 | 404.77 Mn |
| Sep 30, 2022 | 404.15 Mn |
| Jun 30, 2022 | 403.53 Mn |
| Mar 31, 2022 | 402.92 Mn |
| Dec 31, 2021 | 339.27 Mn |
| Sep 30, 2021 | 326.15 Mn |
| Jun 30, 2021 | 321.71 Mn |
| Mar 31, 2021 | 317.34 Mn |
| Dec 31, 2020 | 313.03 Mn |
| Sep 30, 2020 | 456.46 Mn |
API Access
Pacira BioSciences Convertible Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=convertible-debt&ticker=PCRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "convertible-debt", "ticker": "PCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=convertible-debt&ticker=PCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();